A
BVS icon

AlphaQuest’s Bioventus BVS Stock Holding History

AlphaQuest’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,390
Closed -$204K – 310
2025
Q4 		$204K Hold
27,390
– – 0.01% 1440
2025
Q3 		$183K Sell
27,390
-3,083
-10% -$21.4K 0.01% 1454
2025
Q2 		$202K Buy
30,473
+22,872
+301% +$162K 0.02% 1126
2025
Q1 		$69.5K Sell
7,601
-31,163
-80% -$311K 0.01% 1433
2024
Q4 		$407K Buy
38,764
+34,505
+810% +$408K 0.05% 581
2024
Q3 		$50.9K Buy
+4,259
New +$36.8K ﹤0.01% 1408

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AlphaQuest's BVS Position: Q1 2026 in Review

AlphaQuest sold out of Bioventus (BVS) in Q1 2026, closing a stake of 27,390 shares — an estimated $204K sold.

AlphaQuest first reported a position in BVS in Q3 2024 and held it in 6 quarters. The position peaked at $407K in Q4 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • AlphaQuest reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 27,390 Bioventus shares in Q1 2026, an estimated $204K.
  • AlphaQuest first reported a position in Bioventus in Q3 2024 and held it in 6 quarters.
  • AlphaQuest's Bioventus position peaked at $407K in Q4 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.